Complejo Asistencial Universitario de Salamanca

Salamanca 37007

0 studies enrolling now · 7 studies all time

What they study most

Acute Myeloid Leukemia, Chronic Spontaneous Urticaria, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphocytic Leukemia, Chronic, Lymphoma, Non Hodgkin, Moderate Aortic Valve Stenosis, Multiple Myeloma, Myelodysplastic Syndromes, Pyoderma Gangrenosum

Studies at this site

• A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma — Running, not enrolling
• Evolut™ EXPAND TAVR II Pivotal Trial — Running, not enrolling
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
• Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum — Stopped early
• Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2 — Running, not enrolling
• A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) — Completed
• A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes — Stopped early